Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

23 May 2023: Original Paper

Safety and Efficacy of 4 mg·kg Sugammadex for Simultaneous Pancreas-Kidney Transplantation Recipients: A Prospective Randomized Trial

Jiancheng Tang 12ABCDEFG , Rongzhi He 2ABCEF , Lei Zhang 3ABD , Shiyuan Xu 1ABCDEFG*

DOI: 10.12659/AOT.940211

Ann Transplant 2023; 28:e940211

Figure 4 (A) Time of recovery to TOF=0.7/0.9 for both groups. (B) Extubation time and length of PACU stay in both groups. Scr and AMS at T2–6 were significantly lower than that at T0–1 (P<0.01), CCr at T2–6 was significantly higher than that at T0–1 (P<0.01). There was no significantly significant difference in the concentration of Scr, CCr, and AMS between the 2 groups at the same timepoint (P>0.05). MAP, HR, and Glu at T1 in group S were higher compared with group N (P<0.05). MAP – mean arterial pressure; HR – heart rate; Scr – serum creatinine; CCr – creatinine clearance rate; AMS – serum amylase, Glu – blood glucose; S – sugammadex; N – neostigmine. T0, the start of surgery; 8 hours (T1), 12 hours (T2), 36 hours (T3), 60 hours (T4), 84 hours (T5), and 108 hours (T6) after the surgery completed. (This figure was made using Microsoft® Excel® 2019MSO (2303 Build 16.0.16227.20202) 64, Microsoft Corporation).

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358